Literature DB >> 23416853

Finding the sweet spot for donor lymphocyte infusions.

Hyun Don Yun1, Edmund K Waller.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23416853     DOI： 10.1016/j.bbmt.2013.02.005

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  10 in total

1.  A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation.

Authors:  Sarah Nikiforow; Haesook T Kim; Heather Daley; Carol Reynolds; Kyle Thomas Jones; Philippe Armand; Vincent T Ho; Edwin P Alyea; Corey S Cutler; Jerome Ritz; Joseph H Antin; Robert J Soiffer; John Koreth
Journal:  Haematologica       Date:  2016-06-27       Impact factor: 9.941

2.  Low blood lymphocyte count at 30 days post transplant predicts worse acute GVHD and survival but not relapse in a large retrospective cohort.

Authors:  Z Gul; E Van Meter; M Abidi; I Ditah; M Abdul-Hussein; A Deol; L Ayash; L G Lum; E K Waller; V Ratanatharathorn; J Uberti; Z Al-Kadhimi
Journal:  Bone Marrow Transplant       Date:  2015-01-19       Impact factor: 5.483

Review 3.  The role of the thymus in allogeneic bone marrow transplantation and the recovery of the peripheral T-cell compartment.

Authors:  Enrico Velardi; Emmanuel Clave; Franco Locatelli; Antoine Toubert; Lucas C M Arruda; Francesca Benini
Journal:  Semin Immunopathol       Date:  2021-01-08       Impact factor: 9.623

4.  Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion.

Authors:  Pavan Bachireddy; Ursula Hainz; Michael Rooney; Olga Pozdnyakova; Julie Aldridge; Wandi Zhang; Xiaoyun Liao; F Stephen Hodi; Karyn O'Connell; W Nicholas Haining; Natalie R Goldstein; Christine M Canning; Robert J Soiffer; Jerome Ritz; Nir Hacohen; Edwin P Alyea; Haesook T Kim; Catherine J Wu
Journal:  Blood       Date:  2013-12-19       Impact factor: 22.113

Review 5.  Graft versus tumor effects and why people relapse.

Authors:  J H Frederik Falkenburg; Inge Jedema
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

6.  Irradiation of peripheral blood mononuclear cells with 7.5 Gy X-rays prior to donor lymphocyte infusion inhibits proliferation while preserving cytotoxicity, and improves the effectiveness of HSCT in patients with hematological malignancies.

Authors:  Yong-Qiu Wei; Xi-Nan Cen; Hui-Hui Liu; Yu-Hua Sun; Yong-Jin Shi; Wei Liu; Yu-Jun Dong; Han-Yun Ren
Journal:  Oncol Lett       Date:  2017-03-31       Impact factor: 2.967

7.  The allogeneic HLA-DP-restricted T-cell repertoire provoked by allogeneic dendritic cells contains T cells that show restricted recognition of hematopoietic cells including primary malignant cells.

Authors:  Aicha Laghmouchi; Conny Hoogstraten; Peter van Balen; J H Frederik Falkenburg; Inge Jedema
Journal:  Haematologica       Date:  2018-09-20       Impact factor: 9.941

Review 8.  Immunological and Clinical Impact of Manipulated and Unmanipulated DLI after Allogeneic Stem Cell Transplantation of AML Patients.

Authors:  Jochen Greiner; Marlies Götz; Donald Bunjes; Susanne Hofmann; Verena Wais
Journal:  J Clin Med       Date:  2019-12-23       Impact factor: 4.241

Review 9.  Prevention and Treatment of Acute Myeloid Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The State of the Art and Future Perspectives.

Authors:  Salvatore Leotta; Annalisa Condorelli; Roberta Sciortino; Giulio Antonio Milone; Claudia Bellofiore; Bruno Garibaldi; Giovanni Schininà; Andrea Spadaro; Alessandra Cupri; Giuseppe Milone
Journal:  J Clin Med       Date:  2022-01-04       Impact factor: 4.241

Review 10.  Allogeneic Stem Cell Transplantation Platforms With Ex Vivo and In Vivo Immune Manipulations: Count and Adjust.

Authors:  Moniek de Witte; Laura G M Daenen; Lotte van der Wagen; Anna van Rhenen; Reiner Raymakers; Kasper Westinga; Jürgen Kuball
Journal:  Hemasphere       Date:  2021-06-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.